ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND SOLUBILITY ESTIMATION OF NICARDIPINE HCL IN VARIOUS OIL SOLVENTS, SURFACTANTS AND COSURFACTANTS

RAHUL Y. PAGAR; AVINASH B. GANGURDE

doi:10.22159/ijap.2024v16i4.51264

Authors

RAHUL Y. PAGAR Department of Pharmaceutics, K.B.H.S.S. Trust’s Institute of Pharmacy, Malegaon, Nashik-423105, Maharashtra, India https://orcid.org/0000-0002-4403-3096
AVINASH B. GANGURDE Department of Pharmaceutics, K.B.H.S.S. Trust’s Institute of Pharmacy, Malegaon, Nashik-423105, Maharashtra, India https://orcid.org/0000-0003-2674-7770

DOI:

https://doi.org/10.22159/ijap.2024v16i4.51264

Keywords:

Solubility, Bioavailability, Nicardipine HCl, Caprylic capric, Tween 80, Transcutol HP

Abstract

Objective: This study is focused on the development of an analytical method and the evaluation of the solubility of Nicardipine HCl (NHCL) in various oil solvents, surfactants, and cosurfactants using the saturated solubility determination method employing UV Spectrophotometry.

Methods: Lipophilic solvents such as Caprylic Capric, Soyabean oil, Linseed oil, Coconut oil, Sunflower oil, Corn oil, Olive oil, Peanut oil, and Cottonseed oil were utilized, along with surfactants Tween 60 and Tween 80, and cosurfactants PEG 200 and Transcutol HP. Analytical validation parameters, including linearity and range, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), ruggedness, robustness, and accuracy, were assessed according to the International Council for Harmonisation (ICH) guidelines. The solubility of NHCL in all of the aforementioned solvents was evaluated using the saturated solubility determination method.

Results: Linearity analysis revealed a linear relationship, determined by an R² value between concentration and absorbance. Intra-day precision demonstrates method reliability, with all Percent Relative Standard Deviation (%RSD) values ranging between 0.8426 and 1.9417%. LOD and LOQ values ranged between 2.3366 and 6.2405 µg/ml and 8.3197 and 18.905 µg/ml, respectively. Ruggedness analysis exhibited good control over external experimental factors, with %RSD between 0.3433 and 1.9183%. Robustness assessment demonstrated consistent performance even with slight changes in environmental conditions, with %RSD between 0.5450 and 1.6443%. Accuracy study indicated % recovery values between 98.53 and 100.89%, suggesting minimal interference from excipients in the formulation.

Conclusion: Caprylic Capric, as an oil/triglyceride, exhibited a solubility of 0.94 mg/ml. Tween-80, as a surfactant, showed a solubility of 23.58 mg/ml, and Transcutol HP, as a cosurfactant, demonstrated a solubility of 38.18 mg/ml for NHCL

Downloads

Download data is not yet available.

References

Singh BN, Josephson MA. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. Am Heart J. 1990;119(2):427–34. doi:http://dx.doi.org/10.1016/s0002-8703(05)80063-8

Moursy NM, Afifi NN, Ghorab DM, El-Saharty Y. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride. Pharmazie. 2003;58(1):38–43.

Sorkin EM, Clissold SP. Nicardipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs. 1987 Apr;33(4):296-345.doi: http://dx.doi.org/10.2165/00003495-198733040-00002

Selvam RP, Singh AK, Sivakumar T. Transdermal drug delivery systems for antihypertensive drugs-A review. Int J Pharm Biomed Res. 2010;1(1):1-8.

Elliott WJ, Ram CV. Calcium channel blockers. The Journal of Clinical Hypertension. 2011;13(9):687.

Chavda HV, Patel CN, Anand IS. Biopharmaceutics classification system. Syst Rev Pharm .2010;1(1):62. doi: http://dx.doi.org/10.4103/0975-8453.59514

Charalabidis A, Sfouni M, Bergström C, Macheras P. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines. Int J Pharm. 2019;566:264–81. doi: http://dx.doi.org/10.1016/j.ijpharm.2019.05.041

Mehta M, Polli JE, Seo P, Bhoopathy S, Berginc K, Kristan K, et al. Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop summary report. J Pharm Sci .2023;112(7):1749–62. doi: http://dx.doi.org/10.1016/j.xphs.2023.04.016

Mehta S, Joseph NM, Feleke F, Palani S. Improving solubility of bcs class ii drugs using solid dispersion: A review. J Drug DelivTher . 2014;4(3). doi:http://dx.doi.org/10.22270/jddt.v4i3.844

Sarisaltik YD, Teksi̇n ZŞ. Biopharmaceutics classification system (BCS): Evaluation on international guidelines and countries. J Lit Pharm Sci . 2018;7(2):doi:http://dx.doi.org/10.5336/pharmsci.2018-61223

Jindal K. Review on solubility: A mandatory tool for pharmaceuticals. Int Res J Pharm . 2017;8(11):11–5. doi:http://dx.doi.org/10.7897/2230-8407.0811210

Kumar A, Rajesh M, Subramanian L. Solubility enhancement techniques: A comprehensive review. World J Bio Pharm Health Sci. 2023;13(3):414–149. doi:http://dx.doi.org/10.30574/wjbphs.2023.13.3.0125

Saxena C, Mishra GP. Comprehensive study about solubility enhancement techniques. Int J Biol Pharm Allied Sci . 2022;11(9). doi:http://dx.doi.org/10.31032/ijbpas/2021/11.9.6220

Savjani KT, Gajjar AK, Savjani JK. ChemInform abstract: Drug solubility: Importance and enhancement techniques. ChemInform. 2013;44(26). doi:http://dx.doi.org/10.1002/chin.201326246

Coltescu AR, Butnariu M, Sarac I. The importance of solubility for new drug molecules. Biomed Pharmacol J. 2020;13(02):577–83. doi:http://dx.doi.org/10.13005/bpj/1920

Koch-Weser J. Bioavailability of drugs. N Engl J Med. 1974;291(10):503–6. doi:http://dx.doi.org/10.1056/nejm197409052911005

Stielow M, Witczyńska A, Kubryń N, Fijałkowski Ł, Nowaczyk J, Nowaczyk A. The bioavailability of drugs-the current state of knowledge. Molecules . 2023;28(24):1-19. doi:http://dx.doi.org/10.3390/molecules28248038

Allam AN, El Gamal S, Naggar V. Bioavailability: A pharmaceutical review. Int J Novel Drug Deliv Tech. 2011 Jan;1(1):77-93.

Patil D, Bachhav R, Gosavi D, Pagar R, Bairagi V. Formulation and evaluation of Ezetimibe lyophilized dry emulsion tablets. Journal of Drug Delivery and Therapeutics. 2019;9(3):630-5.

Gaidhani KA, Harwalkar M, Bhambere D, Nirgude PS. Lyophilization/freeze drying–a review. World journal of pharmaceutical research. 2015;4(8):516-43.

Pagar RY, Gangurde AB. Quality by design approach for development of lyophilized dry emulsion tablets (LDET). J Chem Health Risks. 2024;14(2):815–27. doi: https://jchr.org/index.php/JCHR/article/view/3532

Dhahir RK, YassirABF, Al-KotajiM, Rawas-Qalaji M. Formulation and Evaluation of Olanzapine Oral Lyophilisates. Pharmakeftiki. 2024;36(1):64-79.

AlHusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. European journal of pharmaceutics and biopharmaceutics. 2011;79(3):627-34.

Shao H, Li B, Li H, Gao L, Zhang C, Sheng H, Zhu L. Novel strategies for solubility and bioavailability enhancement of bufadienolides. Molecules. 2021;27(1):51.

Corveleyn S, Remon JP. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm. 1998;166(1):65–74. doi: http://dx.doi.org/10.1016/s0378-5173(98)00024-6

Maleque M, Hasan MR, Hossen F, Safi S. Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations. J Pharm Anal. 2012;2(6):454–7. doi: http://dx.doi.org/10.1016/j.jpha.2012.06.004

Ferraz RS, Mendonça EAM, Silva JPA, Cavalcanti IMF, Lira-Nogueira MCB, Galdino SL, et al. Validation of a UV-spectrophotometric analytical method for determination of LPSF/AC04 from inclusion complex and liposomes. Braz J Pharm Sci.2015;51(1):183–91. doi: https://www.scielo.br/j/bjps/a/QYzGjzHzZ6hj4sJZRTh8h4p/?format=pdf&lang=en

Pathade P, Sumrao A, Sonawane B, Shirode D, Shewale S, Shinde V, et al. Development and validation of stability indicating UV spectrophotometric method for estimation of resveratrol in bulk and tablet dosage form. Int J Drug DelivTechnol2024;14(01):385–8. doi:http://impactfactor.org/PDF/IJDDT/14/IJDDT,Vol14,Issue1,Article56.pdf

Rajesh R. Stability-indicating RP-HPLC method development and validation for the analysis of Doxepin Hydrochloride in bulk and pharmaceutical dosage form. Int J Pharm Pharm Sci. 2024; 16(4):27-5. doi: http://dx.doi.org/10.22159/ijpps.2024v16i4.50126

Bodke SS, Bhangale CJ, Bhandare SN. Stability indicating UPLC method for estimation of benazepril and hydrochlorothiazide in bulk and combined dosage form. Int J Pharm Pharm Sci. 2024; 16(1):22–29. doi: http://dx.doi.org/10.22159/ijpps.2024v16i1.49457

Chauhan I, Singh L. Development and validation of a simple and cost-effective UV spectrophotometric method for quantifying Linezolid. Int J Appl Pharm. 2024; 16(3):211–6. doi: http://dx.doi.org/10.22159/ijap.2024v16i3.50556

Bhavya SK, Nandhini M. Simultaneous method development and validation of combined dosage form Dapagliflozin and Vildagliptin in bulk and combined tablet dosage form by UV spectrophotometer. Asian J Pharm Clin Res. 2024; 17(4):53-9. doi: https://journals.innovareacademics.in/index.php/ajpcr/article/view/49083/29980

Jothula H, Navuluri S, Mulakayala NR. Stability based HPLC method for cyclophosphamide related substances in finished drug products: Development and validation. Int J Curr Pharm Res. 2024; 16(3):42–1. doi: http://dx.doi.org/10.22159/ijcpr.2024v16i3.4061

Baka E, Comer JEA, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46(2):335–41. doi: http://dx.doi.org/10.1016/j.jpba.2007.10.030

Naik AD, Pai SPN. Spectrophotometric method for estimation of linezolid in tablet formulation. Asian J Biomed Pharm Sci. 2013;3(21):4-6

Nagaraju PT, Sreenivasa Rao M, Ravi Kumar C, Mabhasha D, Venu Gopal K, Murali Krishna NV. UV-spectrophotometric method development and validation for determination of linezolid in pharmaceutical dosage form. Res Rev J Pharm Anal. 2014;3(3):23-7

Apridamayanti P, Pratiwi L, Sari R. The development and validation of analytical method for evaluating Gallic acid in ethyl acetate fraction (eaf) of snedds formulation: Quantitative analysis with in vitro assay. Int J Appl Pharm. 2024;57–65. https://journals.innovareacademics.in/index.php/ijap/article/view/49830

Patil PN. HPLC method development-a review. SGVU J Pharm Res. 2017; 2(1):243-60.

Snyder L, Kirkland J, Dolan J. Introduction to modern liquid Chromatography. 3rd ed, John. NJ: Wileyandsonsinc.; 2010.

Kaur T, Kaur S, Kaur P. Development and validation of UVspectrophotometric methods for determination of gemcitabine hydrochloride in bulk and polymeric nanoparticles. Int J App Pharm. 2017;9(5):60-5. doi: 10.22159/ijap.2017v9i5.19726.

Shirwar M, Birajdar S, Garad S, Kumbhar S. Development and validation of novel UV-visible spectrophotometric method for estimation of tepotinib in bulk and in pharmaceutical formulation. Int J Pharm Pharm Sci. 2023;15(9):32-6. doi: 10.22159/ijpps.2023v15i9.48431.

Singh S, Sharma N, Singla YP, Arora S. Development and validation of UV-spectrophotometric method for quantitative estimation of nefopam hydrochloride in polymethacrylate nanospheres. Int J Pharm Pharm Sci. 2015;8(1):414-9.

Swartz ME, Krull IS. Analytical method validation: accuracy in quantitation. LC GC N Am. 2005;23(1):46-52.